MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 113 filers reported holding MERUS N V in Q2 2023. The put-call ratio across all filers is 1.53 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,770,132 | +56.9% | 838,428 | +75.2% | 0.53% | +76.7% |
Q2 2023 | $12,599,721 | +288.8% | 478,531 | +173.6% | 0.30% | +117.4% |
Q1 2018 | $3,241,000 | -38.6% | 174,917 | -35.7% | 0.14% | -42.3% |
Q4 2017 | $5,276,000 | -3.4% | 271,952 | -1.1% | 0.24% | -5.2% |
Q3 2017 | $5,464,000 | -14.2% | 275,000 | -31.6% | 0.25% | -21.7% |
Q2 2017 | $6,372,000 | -32.1% | 402,000 | +4.5% | 0.32% | -40.5% |
Q1 2017 | $9,379,000 | +11.1% | 384,548 | -3.9% | 0.54% | -4.2% |
Q4 2016 | $8,444,000 | +31.6% | 400,000 | +4.4% | 0.56% | +40.5% |
Q3 2016 | $6,415,000 | +122.5% | 383,000 | +6.1% | 0.40% | +88.7% |
Q2 2016 | $2,883,000 | – | 360,811 | – | 0.21% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $32,048,000 | 13.34% |
Lynx1 Capital Management LP | 613,071 | $12,280,000 | 11.08% |
Aquilo Capital Management, LLC | 1,507,109 | $30,187,000 | 10.88% |
COMMODORE CAPITAL LP | 2,615,762 | $52,394,000 | 8.42% |
MPM BioImpact LLC | 918,310 | $18,394,000 | 4.36% |
BVF INC/IL | 3,444,420 | $68,992,000 | 2.85% |
Boxer Capital, LLC | 1,900,000 | $38,057,000 | 2.14% |
Opaleye Management Inc. | 253,200 | $5,072,000 | 2.10% |
SILVERARC CAPITAL MANAGEMENT, LLC | 295,136 | $5,912,000 | 2.00% |
TCG Crossover Management, LLC | 300,000 | $6,009,000 | 1.80% |